focus -WSS

focus

author：fashion 2025-09-30 18:21:34 - browse：3

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

hotspot

explore

WSS

Kenai launches with $82 million for Parkinson’s stem cell therapy

Stop the failed accountable care organization experiment

Clinical trials giant ICON acquires HumanFirst

Scientists unlock the key to scar

FDA does about

Plastic surgeons increase patient psychiatric screenings

focus

focus

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Positive childhood experiences can help future health

After affirmative action ruling, medical educators look to 'holistic review'

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Hollywood unions extend contract negotiations for actors

Baby aspirin cuts fat buildup in liver disease patients, in small study

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

State Dept. review finds Biden bears some blame for Afghanistan failures

AstraZeneca loses challenge to Medicare drug price negotiation

leisure time

FDA does about

FogPharma raises $145 million in rare Series E round

Intermittent fasting comes with a heart risk? Not so fast

Gene editing the human germline: What are the risks?

Future doctors should be trained to promote social change

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

focus

hotspot

explore

focus